Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: An epidemiological and structural perspective

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 8, 2014, Pages 2065-2075

  Alm, Richard A ^a   McLaughlin, Robert E ^a   Kos, Veronica N ^a   Sader, Helio S ^b   Iaconis, Joseph P ^a   Lahiri, Sushmita D ^a  

^a ASTRAZENECA   (United Kingdom)

^b JMI LABORATORIES   (United States)

Author keywords

MRSA; Penicillin binding proteins; Resistance

Indexed keywords

BETA LACTAM; CEFTAROLINE; PENICILLIN BINDING PROTEIN 2A; TRANSPOSASE; ANTIINFECTIVE AGENT; BACTERIAL DNA; CEPHALOSPORIN DERIVATIVE; PENICILLIN BINDING PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; GENE SEQUENCE; GENETIC ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PROTEIN STRUCTURE; X RAY ANALYSIS; BACTERIUM IDENTIFICATION; CHEMICAL STRUCTURE; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; NUCLEOTIDE SEQUENCE; STAPHYLOCOCCAL INFECTIONS; ULTRASTRUCTURE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BASE SEQUENCE; CEPHALOSPORINS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PENICILLIN-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS;

EID: 84904564037     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku114     Document Type: Article

References (43)

1. Saravolatz LD, Stein GE, Johnson LB. Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2011; 52: 1156-63.
2. Biek D, Critchley IA, Riccobene TA et al. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity. J Antimicrob Chemother 2010; 65 Suppl 4: iv9-16.
3. Ishikawa T, Matsunaga N, Tawada H et al. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties. Bioorg Med Chem 2003; 11: 2427-37.
4. Deurenberg RH, Vink C, Kalenic S et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007; 13: 222-35.
5. Nubel U, Dordel J, Kurt K et al. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillinresistant Staphylococcus aureus. PLoS Pathog 2010; 6: e1000855.
6. Berger-Bachi B, Tschierske M. Role of fem factors in methicillin resistance. Drug Resist Updat 1998; 1: 325-35.
7. Berger-Bachi B, Rohrer S. Factors influencing methicillin resistance in staphylococci. Arch Microbiol 2002; 178: 165-71.
8. Tschierske M, Mori C, Rohrer S et al. Identification of three additional femAB-like open reading frames in Staphylococcus aureus. FEMS Microbiol Lett 1999; 171: 97-102.
9. Rohrer S, Ehlert K, Tschierske M et al. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc Natl Acad Sci USA 1999; 96: 9351-6.
10. Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469-74.
11. Holden MT, Hsu LY, Kurt K et al. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res 2013; 23: 653-64.
12. McAdam PR, Templeton KE, Edwards GF et al. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2012; 109: 9107-12.
13. Koser CU, Holden MT, Ellington MJ et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012; 366: 2267-75.
14. Eyre DW, Golubchik T, Gordon NC et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2012; 2: e001124.
15. Harris SR, Cartwright EJ, Torok ME et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis 2013; 13: 130-6.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, USA, 2013.
17. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/ Breakpoint_tables/Breakpoint_table_v_3.1.pdf (20 November 2013, date last accessed).
18. Zhang K, McClure JA, Conly JM. Enhanced multiplex PCR assay for typing of staphylococcal cassette chromosome mec types I to V in methicillinresistant Staphylococcus aureus. Mol Cell Probes 2012; 26: 218-21.
19. Hyatt D, Chen GL, Locascio PF et al. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics 2010; 11: 119-29.
20. Li L, Stoeckert CJ Jr, Roos DS. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res 2003; 13: 2178-89.
21. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimumevolution trees with profiles instead of a distance matrix. Mol Biol Evol 2009; 26: 1641-50.
22. Howden BP, Seemann T, Harrison PF et al. Complete genome sequence of Staphylococcus aureus strain JKD6008, an ST239 clone of methicillin-resistant Staphylococcus aureus with intermediate-level vancomycin resistance. J Bacteriol 2010; 192: 5848-9.
23. Li Y, Cao B, Zhang Y et al. Complete genome sequence of Staphylococcus aureus T0131, an ST239-MRSA-SCCmec type III clone isolated in China. J Bacteriol 2011; 193: 3411-2.
24. Kuroda M, Ohta T, Uchiyama I et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001; 357: 1225-40.
25. Vogel V, Falquet L, Calderon-Copete SP et al. Short term evolution of a highly transmissible methicillin-resistant Staphylococcus aureus clone (ST228) in a tertiary care hospital. PLoS One 2012; 7: e38969.
26. Mendes RE, Tsakris A, Sader HS et al. Characterization of methicillinresistant Staphylococcus aureus displaying increased MICs of ceftaroline. J Antimicrob Chemother 2012; 67: 1321-4.
27. Aritaka N, Hanaki H, Cui L et al. Combination effect of vancomycin and b-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother 2001; 45: 1292-4.
28. BergeretM, Boutros N, Raymond J. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillinresistant staphylococci. Int J Antimicrob Agents 2004; 23: 247-53.
29. Menegotto F, Gonzalez-Cabrero S, Cubero A et al. Clonal nature and diversity of resistance, toxins and adhesins genes of meticillin-resistant Staphylococcus aureus collected in a Spanish hospital. Infect Genet Evol 2012; 12: 1751-8.
30. Chongtrakool P, Ito T, Ma XX et al. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother 2006; 50: 1001-12.
31. Jariyasethpong T, Tribuddharat C, Dejsirilert S et al. MRSA carriage in a tertiary governmental hospital in Thailand: emphasis on prevalence and molecular epidemiology. Eur J Clin Microbiol Infect Dis 2010; 29: 977-85.
32. Witte W, Cuny C, Klare I et al. Emergence and spread of antibiotic-resistant gram-positive bacterial pathogens. Int J Med Microbiol 2008; 298: 365-77.
33. Clark C, McGhee P, Appelbaum PC et al. Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria. Antimicrob Agents Chemother 2011; 55: 2344-51.
34. Lovering AL, Gretes MC, Safadi SS et al. Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole. J Biol Chem 2012; 287: 32096-102.
35. Lim D, Strynadka NC. Structural basis for the b lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat Struct Biol 2002; 9: 870-6.
36. Davies TA, Page MG, Shang W et al. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrob Agents Chemother 2007; 51: 2621-4.
37. Banerjee R, Gretes M, Basuino L et al. In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52: 2089-96.
38. Kosowska-Shick K, McGhee PL, Appelbaum PC. Affinity of ceftaroline and other b-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother 2010; 54: 1670-7.
39. Leski TA, Tomasz A. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J Bacteriol 2005; 187: 1815-24.
40. Pinho MG, de Lencastre H, Tomasz A. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc Natl Acad Sci USA 2001; 98: 10886-91.
41. Farha MA, Leung A, Sewell EWet al. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to b-lactams. ACS Chem Biol 2013; 8: 226-33.
42. Lovering AL, de Castro LH, Lim D et al. Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis. Science 2007; 315: 1402-5.
43. Moisan H, Pruneau M, Malouin F. Binding of ceftaroline to penicillinbinding proteins of Staphylococcus aureus and Streptococcus pneumoniae. J Antimicrob Chemother 2010; 65: 713-6.